Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.

Article Details

Citation

Otto F, Kanegane H, Mundlos S

Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.

Hum Mutat. 2002 Mar;19(3):209-16. doi: 10.1002/humu.10043.

PubMed ID
11857736 [ View in PubMed
]
Abstract

Cleidocranial dysplasia (CCD) is a autosomal dominant disorder characterized by skeletal anomalies such as patent fontanels, late closure of cranial sutures with Wormian bones, late erupting secondary dentition, rudimentary clavicles, and short stature. The locus for this disease was mapped to chromosome 6p21. RUNX2 is a member of the runt family of transcription factors and its expression is restricted to developing osteoblasts and a subset of chondrocytes. Mutations in the RUNX2 gene have been shown to cause CCD. Chromosomal translocations, deletions, insertions, nonsense and splice-site mutations, as well as missense mutations of the RUNX2 gene have been described in CCD patients. Although there is a wide spectrum in phenotypic variability ranging from primary dental anomalies to all CCD features plus osteoporosis, no clear phenotype-genotype correlation has been established. However analysis of the three-dimensional structure of the DNA binding runt domain of the RUNX proteins and its interaction with DNA, as well as the cofactor CBFB, start to provide an insight into how missense mutations affect RUNX2 function.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Runt-related transcription factor 2Q13950Details